Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus management
Topically used drugs must pass through the barrier to reach the underlying live cells while combating the exudate transport occurring in the reverse direction, and therefore, the bioavailability of topical drugs is greatly reduced
INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours
To investigate the depletion of O 2 within the cells, cancer cells in a 1% O 2 atmosphere were treated with Ru(II)-OH, NP2, or NP4, and the O 2 concentration was assessed using the hypoxia probe pimonidazole hydrochloride
Your PlexusDx provider can review whether your current tirzepatide dose is appropriate, whether a slower dose escalation schedule might reduce early GI side effects, or whether switching to the oral formulation (if you're on injections) or vice versa might help